About Alida Biosciences
Alida Biosciences is a private company based in San Diego, California, incorporated in 2020 in Delaware. It has reported $12,030,383 raised in three offerings on Form D since July 2021. Its chief executive is Gudrun Stengel.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 7, 2024 | Jun 17, 2024 | $7,520,384of $8.5M target | 3 | $2.5M | EquityRule 506(b) | Form D ↗ |
| May 11, 2022 | May 23, 2022 | $3,999,999fully sold | 2 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Jun 21, 2021 | Jul 2, 2021 | $510,000of $1.1M target | 4 | $127K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $12,030,383 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alida Biosciences's Form D filed Jun 17, 2024.
LM
Landon Merrill
Director
GS
Gudrun Stengel
President and CEO, director
PC
Paul Conley
Director
JD
John Drewry
Director